1.	Upper Vaginectomy Versus Brachytherapy in Patients With Early Stage Endometrial Cancer Treated With Laparoscopic Surgery Phase: Phase IV Type: Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: 03/2007, NCT00719017
2.	Effects of Gum Chewing on Recovery of Bowel Function Following Abdominal Surgery for Endometrial and Ovarian Cancer Phase: Phase III, Phase II Type: Supportive care Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: GUM-ET/OV, NCT01389986
3.	Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer Phase: Phase III Type: Treatment Status: Active Age: Not specified Sponsor: Other Protocol IDs: CDR0000521447; P06.031, CKTO-2006-04, ISRCTN14387080, P06.031-PORTEC-3, 2007-004917-33, CKTO-PORTEC-3, EU-20664, NCT00411138
4.	Prospective Randomized Open Label Study of the Treatment of Therapy-Associated Diarrhea During Percutaneous Radiation Therapy of the Small Pelvis. - Comparison of Loperamide and Tincture of Opium - Phase: Phase III Type: Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other Protocol IDs: 2006-002948-28, KKS-73-05, NCT00444093
5.	The Addition of Polychemotherapy to Adjuvant Radiotherapy in the Treatment of Non-Metastatic Uterine Sarcomas Phase: Phase III Type: Treatment Status: Active Age: 18 to 65 Sponsor: Other Protocol IDs: SARC-GYN1, NCT00162721
6.	Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 2 to 21 Sponsor: NCI Protocol IDs: SCUSF-0703, MCC-0703, SCUSF 0703, NCT01132547
7.	Trial of Collagen Mesh for Prevention of Ventral Hernia After Surgery for Advanced Pelvic Cancer Phase: Phase III Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: VRAM M-20070240, NCT00647569
8.	The Assessment of Preoperative Psychological Intervention on Stress in Women With Gynecological Malignancies Phase: Phase III Type: Supportive care Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: 0014-08-RMC, NCT00726635
9.	Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: GOG-0249, GOG-0249, NCT00807768
10.	Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients Phase: Phase III Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: TOTEM, NCT00916708
11.	Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 and older Sponsor: NCI Protocol IDs: GOG-0258, GOG-0258, NCT00942357
12.	Study Comparing Isolated Pelvic Perfusion With TNF-a 0.3 mg and Melphalan 1.5 mg/kg Versus Standard Treatment in Patients With Non Resectable, Recurrent Gynaecologic or Digestive Pelvic Cancer Phase: Phase III Type: Treatment Status: Active Age: 18 to 76 Sponsor: Other Protocol IDs: PIP2, CSET 1443, NCT00949039
13.	Letrozole as a Treatment of Endometrial Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 40 and over Sponsor: Other Protocol IDs: 200917341, CFEM 345AUS63, NCT00997373
14.	Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy in Patients With Pelvic Cancer Phase: Phase III Type: Health services research, Supportive care Status: Active Age: Over 18 Sponsor: Other Protocol IDs: CDR0000667367, RMH-CCR3086, EUDRACT-2008-002152-26, EU-21010, MREC-08/H0903/40, NCT01087268
15.	Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer Phase: Phase III Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: ENGOT-EN2-DGCG/EORTC55102, 2010-023081-52, NCT01244789
16.	Efficacy and Safety of the LovenoxTM (Enoxaparin) Versus HeparinTM for Prevention of Venous Thromboembolism in Gynecologic Oncology Patients Phase: Phase III Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: RC08/118, NCT01356329
17.	Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCCTG-N10C1, N10C1, NCT01376349
18.	Intravenous Iron in Gynecologic Cancer Patients Receiving Chemotherapy Phase: Phase III Type: Supportive care Status: Active Age: 20 to 70 Sponsor: Other Protocol IDs: IV iron 2, NCT01435200
19.	Tachosil for the Prevention of Lymph Cysts Phase: Phase III Type: Supportive care Status: Active Age: 18 to 70 Sponsor: Other Protocol IDs: TACH-01, NCT01470677
20.	A Trial Comparing Morcellation With Electrical Resection for Removal of Uterine Polyps Phase: Phase III Type: Treatment Status: Approved-not yet active Age: 16 and over Sponsor: Other Protocol IDs: PPS-MERT-01, NCT01509313
21.	Phase III Study Comparing 3D Conformal Radiotherapy and Conformal Radiotherapy IMRT to Treat Endometrial Cancer Phase: Phase III Type: Treatment Status: Active Age: 70 and over Sponsor: Other Protocol IDs: TOMOGYN - 1105, NCT01641497
22.	Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer Phase: Phase III Type: Biomarker/Laboratory analysis, Supportive care, Treatment Status: Approved-not yet active Age: 18 and over Sponsor: NCI Protocol IDs: RTOG-1203, RTOG 1203, NCT01672892
23.	Fludeoxyglucose F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer Phase: Phase II, Phase I Type: Diagnostic Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: NCI-2009-00600, U10CA080098, CDR0000521453, GOG-0233, ACRIN-6671, NCT00416455
24.	A Clinical Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: BBI608-201, NCT01325441
25.	Phase Ib Trial of Folate Binding Protein Vaccine in Ovarian Cancer Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 05-20025/20288, NCT01580696